Search results for "Degeneration"

showing 10 items of 601 documents

miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis…

2021

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2077-0383/10/11/2227 En esta investigación también participan: Mar Valero Vello, Silvia M. Sanz González, José E. O'Connor, David Galarreta Mira, María D. Pinazo-Durán y Vicente Zanón Moreno. Este artículo pertenece al número especial "Recent Clinical Research on Glaucoma". Glaucoma has no cure and is a sight-threatening neurodegenerative disease affecting more than 100 million people worldwide, with primary open angle glaucoma (POAG) being the most globally prevalent glaucoma clinical type. Regulation of gene expression and gene networks, and its multifactorial pathways involved in glaucoma disease are landmark…

Intraocular pressureBiochemical markers.Open angle glaucomagenetic structuresGlaucomaOcular hypertensionDiseaseBioinformaticsArticle03 medical and health sciences0302 clinical medicineGene expressionmicroRNAApoptosis.Medicineoxidative stressGlaucoma.genes030304 developmental biologyRegulation of gene expressionEstrés oxidativo.next generation sequencing0303 health sciencesbusiness.industryPresión intraocular.apoptosisneurodegenerationIntraocular pressure.RMarcadores bioquímicos.tearsbiomarkersGeneral Medicinemedicine.diseasesignaling pathwayseye diseasesOxidative stress.glaucomainflammationmiRNAs030221 ophthalmology & optometryocular hypertensionMedicinebusinessJournal of Clinical Medicine
researchProduct

PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice …

2022

Abstract Purpose PERSEUS-IT (NCT02289924) was a prospective, observational, 2-year study evaluating the effectiveness and treatment patterns of intravitreal aflibercept (IVT-AFL) in patients with neovascular age-related macular degeneration (nAMD) in routine clinical practice in Italy. Methods Treatment-naïve patients with nAMD receiving IVT-AFL per routine clinical practice were enrolled. The primary endpoint was mean change in visual acuity (VA; decimals) from baseline to month (M) 12 and M24. Outcomes were evaluated for the overall study population and independently for the 2 treatment cohorts: regular (3 initial monthly doses, ≥ 7 injections by M12, and ≥ 4 injections between M12 and M2…

Intravitreal injectionsSettore MED/30 - Malattie Apparato VisivoRecombinant Fusion ProteinsAngiogenesis InhibitorsTreatment outcomesSensory SystemsMacular DegenerationCellular and Molecular NeuroscienceOphthalmologyReceptors Vascular Endothelial Growth FactorTreatment OutcomeRanibizumabObservational studyHumansProspective StudiesAfliberceptNeovascular age-related macular degeneration
researchProduct

Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis

2019

Advanced neuroimaging has increased understanding of the pathogenesis and spread of disease, and offered new therapeutic targets. MRI and positron emission tomography have shown that neurodegenerative diseases including Alzheimer’s disease (AD), Lewy body dementia (LBD), Parkinson’s disease (PD), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) are associated with changes in brain networks. However, the underlying neurophysiological pathways driving pathological processes are poorly defined. The gap between what imaging can discern and underlying pathophysiology can now be addressed by advanced techniques that explore the cortical neural synchro…

Lewy Body Diseasemedicine.medical_treatmentElectroencephalographysurgery03 medical and health sciences0302 clinical medicineNeuroimagingAlzheimer DiseasemedicineDementiaHumans1506Amyotrophic lateral sclerosisNeurodegeneration030304 developmental biologyneurology (clinical)0303 health sciencesLewy bodymedicine.diagnostic_testbusiness.industryAmyotrophic Lateral Sclerosissurgery; neurology (clinical); psychiatry and mental healthMagnetoencephalographyElectroencephalographyNeurodegenerative DiseasesParkinson DiseaseMagnetoencephalographymedicine.diseaseTranscranial Magnetic Stimulation3. Good healthTranscranial magnetic stimulationpsychiatry and mental healthFrontotemporal DementiaNerve NetbusinessNeuroscience030217 neurology & neurosurgeryFrontotemporal dementiaJournal of Neurology, Neurosurgery, and Psychiatry
researchProduct

Acute and reversible Pisa syndrome as unusual presentation of portosystemic encephalopathy

2020

Abstract We present the first case of acute and reversible Pisa Syndrome, as a clinical manifestation of a portosystemic encephalopathy bout occurring in a patient affected with cirrhosis and clinical-radiological signs of acquired hepatocerebral degeneration, without exposure to psychotropic medications. A 62 year-old man suffering from cirrhosis was admitted to our hospital for sudden onset of mild confusion and postural change. He was observed walking and standing with a tilt toward the right during the last two hours. On neurological examination, he showed bilateral asterixis and extrapyramidal signs. Clinical diagnosis of Pisa Syndrome was made in a setting of raised serum ammonia. A b…

Liver CirrhosisMalemedicine.medical_specialtyCerebellumCirrhosisNeurological examination03 medical and health sciences0302 clinical medicineNeuroimagingAcquired hepatocerebral degenerationInternal medicineBasal gangliaHumansMedicinePortosystemic encephalopathyAsterixisPisa syndrome Axial dystonia Portosystemic encephalopathy Acquired hepatocerebral degeneration Orthotopic liver transplantmedicine.diagnostic_testbusiness.industryParkinsonismOrthotopic liver transplantGeneral MedicineMiddle Agedmedicine.diseaseAxial dystoniaDystoniaPisa syndromeGlobus pallidusmedicine.anatomical_structureHepatic Encephalopathy030220 oncology & carcinogenesisCardiologySurgeryNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgery
researchProduct

De novo expression of nonhepatocellular cytokeratins in Mallory body formation.

1998

Mallory bodies (MBs) are eosinophilic cytoplasmic inclusions observed predominantly in alcoholic liver disease. Although linked to disease activity, their pathogenesis is still unclear. Since intermediate filaments (cytokeratins) are major components of MBs, their cytokeratin polypeptide composition was analysed with monospecific antibodies for cytokeratins 7, 8, 14, 18, 19, and 20 by immunohistology. MBs were identified by light microscopy and ubiquitin immunostaining. All MBs were positive for cytokeratins 8 and 18. A significant percentage of the MBs was strongly positive for cytokeratins 19 and/or 20, which are not detectable in hepatocytes of normal liver and, in the case of cytokerati…

Liver CirrhosisPathologymedicine.medical_specialtyanimal structuresCarcinoma HepatocellularCytoplasmic inclusionmacromolecular substancesBiologyPathology and Forensic MedicineCytokeratinHepatolenticular DegenerationmedicineMallory bodyHumansIntermediate filamentChildMolecular BiologyLiver Diseases AlcoholicInclusion BodiesLiver DiseasesLiver NeoplasmsAntibodies MonoclonalCell BiologyGeneral Medicinemedicine.diseaseImmunohistochemistryStainingLiverImmunohistochemistryKeratinsEctopic expressionImmunostainingVirchows Archiv : an international journal of pathology
researchProduct

LED Based Dual Wavelength Heterochromatic Flicker Method for Separate Evaluation of Lutein and Zeaxanthin in Retina

2013

The decrease of density and consequentially optical density of macular pigment serves as a diagnostic mean for a number of ophthalmological pathologies, particularly as a risk factor for age related macular degeneration. Macular pigment absorbs light in short wavelength blue spectral range. Thus the optical density of macular pigment can be detected by various optical – both objective and subjective psychophysical techniques. Latter techniques use eye and brain visual pathways as spectral sensitive optical detector and decision maker, and exploit perception facility to process information flow in a unique manner to create various perception illusions. The psychophysical methods of detection…

LuteinRetinaMaterials sciencegenetic structuresbusiness.industryFlickerfood and beveragesMacular degenerationVisual systemmedicine.diseaseeye diseasesZeaxanthinPhotometry (optics)chemistry.chemical_compoundWavelengthOpticsmedicine.anatomical_structurechemistrymedicinesense organsbusiness
researchProduct

Incorporation of lutein and docosahexaenoic acid from dietary microalgae into the retina in quail

2015

Abstract Lutein and docosahexaenoic acid (DHA) are associated with the prevention of age-related macular degeneration (AMD). Since microalgae are potent natural sources of these nutrients, their nutritional value should be evaluated based on the bioavailability of lutein and DHA for the retina via the plasmatic compartment. In this study, quail were fed for 5 months either with a diet supplemented or deprived with microalgae rich in lutein and DHA. In the microalgae-fed group, the retinal concentrations of lutein and zeaxanthin gradually increased whereas in plasma, these compounds started to increase from the first month of supplementation. We also observed a significant increase in retina…

Luteinendocrine systemretinaDocosahexaenoic Acidsgenetic structures030309 nutrition & dietetics[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionBiological Availability03 medical and health scienceschemistry.chemical_compoundMacular Degenerationdha0302 clinical medicineZeaxanthinsbiology.animal[SDV.IDA]Life Sciences [q-bio]/Food engineeringmedicineAnimalsHumansFood scienceage-related macular degeneration2. Zero hunger0303 health sciencesluteinbiologymicroalgaeFood fortification[ SDV.IDA ] Life Sciences [q-bio]/Food engineeringfood and beveragesRetinalquailMacular degenerationmedicine.diseaseQuaileye diseasesBioavailabilityDietZeaxanthinchemistryBiochemistryDocosahexaenoic acidDietary SupplementsModels Animal030221 ophthalmology & optometrysense organs[SDV.AEN]Life Sciences [q-bio]/Food and NutritionFood Science
researchProduct

Xanthophylls: from blood to retina

2010

Xanthophylls are dietary lipophilic compounds. Among them, lutein and zeaxanthin are the major carotenoids found in the human lens and retina, and referred as macular pigment within the retina. Lutein and zeaxanthin cannot be synthesized endogenously. They may therefore be considered as essential and must be provided by adequate dietary intakes. Lutein and zeaxanthin are present in various food items, mainly in plants and fruits such as green vegetables or yellow-orange fruits, as well as in a few animal sources, such as egg yolk. Epidemiological studies consistently suggest that dietary lutein and zeaxanthin are protective factors against the development of Age-Related Maculopathies and Ag…

Luteinfood.ingredientgenetic structuresBiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicinefoodYolkmedicineFood scienceCarotenoidComputingMilieux_MISCELLANEOUSchemistry.chemical_classificationRetinafood and beveragesGeneral MedicineMacular degenerationmedicine.diseaseeye diseases3. Good healthBioavailabilityZeaxanthin[SDV.AEN] Life Sciences [q-bio]/Food and NutritionOphthalmologymedicine.anatomical_structurechemistryBiochemistryXanthophyll030221 ophthalmology & optometrysense organs[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgery
researchProduct

Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease

2016

Charcot-Marie-Tooth disease (CMT) is a complex disorder with wide genetic heterogeneity. Here we present a new axonal Charcot-Marie-Tooth disease form, associated with the gene microrchidia family CW-type zinc finger 2 (MORC2). Whole-exome sequencing in a family with autosomal dominant segregation identified the novel MORC2 p. R190W change in four patients. Further mutational screening in our axonal Charcot-Marie-Tooth disease clinical series detected two additional sporadic cases, one patient who also carried the same MORC2 p. R190W mutation and another patient that harboured a MORC2 p. S25L mutation. Genetic and in silico studies strongly supported the pathogenicity of these sequence vari…

MORC2 genewhole-exome sequencingCharcot-Marie-Tooth diseaseaxonal degenerationSchwann cell
researchProduct

Magnetic Resonance Spectroscopy: principles and clinical applications. Experimental Medicine Reviews

2009

MRS Neurodegeneration Mitochondrial diseases
researchProduct